Altre lingue Coegin Pharma AB

Azioni

COEGIN

SE0020357754

Prezzo di chiusura NORDIC GROWTH MARKET Altri mercati azionari 00:00:00 17/06/2024			Variaz. 5gg	Var. 1 gen.
6,44 ^SEK	+8,05%		+8,05%	+19,59%

23/05	Coegin Pharma AB riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
02/05	Coegin Pharma AB riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Redeye Initiates Coverage of Coegin Pharma	17/06
Coegin Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	23/05
Coegin Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	02/05
Coegin Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/11
Coegin Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/11
Coegin Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25/08/23
Coegin Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2023	25/05/23
Coegin Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2023	25/05/23
Coegin Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	27/02/23
Coegin Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	27/02/23
Coegin Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	24/11/22
Coegin Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	25/08/22
Coegin Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2022	19/05/22
BioStock: Phase I/II data boosts Coegin Pharma	08/04/22
BioStock: Coegin Pharma seeks new opportunities through merger	01/03/22
Coegin Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2021	24/02/22
Coegin Pharma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	24/02/22
Coegin Pharma AS completed the acquisition of Follicum AB.	07/02/22
BioStock: Coegin Pharma aims high in 2022	18/01/22
BioStock: Coegin Pharma takes key steps for growth during Q3	30/11/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Coegin Pharma AB

Azioni

COEGIN

SE0020357754

Altre lingue

Filtri